Cargando…

Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care

In April 2013, the Ministry of Health and Health Sciences Authority of Singapore jointly issued recommendations for HLA-B*15:02 genotyping before starting carbamazepine (CBZ) in new patients of Asian ancestry as standard of care. The Ministry of Health also approved a 75% subsidy for HLA-B*15:02 gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Cynthia, Tan, Liesbet, Limenta, Michael, Ganesan, Ganga, Toh, Dorothy, Chan, Cheng Leng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221117/ https://www.ncbi.nlm.nih.gov/pubmed/32457602 http://dx.doi.org/10.3389/fphar.2020.00527

Ejemplares similares

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
por: Tiwattanon, Kanyawan, et al.
Publicado: (2022)

Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02
por: Simper, Gwendolin S., et al.
Publicado: (2018)

Adverse Drug Reaction Profile of SGLT2 Inhibitor-Associated Diabetic Ketosis/Ketoacidosis in Singapore and their Precipitating Factors
por: Limenta, Michael, et al.
Publicado: (2019)

HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children
por: Amstutz, Ursula, et al.
Publicado: (2013)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
por: Nguyen, Dinh Van, et al.
Publicado: (2015)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
por: Biswas, Mohitosh, et al.
Publicado: (2022)

A Screening Test for HLA-B(∗)15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events
por: Fang, Hua, et al.
Publicado: (2019)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

Comparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug Reactions
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2016)

The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity
por: Simper, Gwendolin S., et al.
Publicado: (2019)

HLA-A*24:02 as a common risk factor for antiepileptic drug–induced cutaneous adverse reactions
por: Shi, Yi-Wu, et al.
Publicado: (2017)

Carbamazepine induced severe cutaneous vasculitis
por: Gutte, Rameshwar M., et al.
Publicado: (2013)

HLA-B*15:02 genotype associated with hypersensitivity syndrome to lamotrigine in Thai population
por: Koomdee, Napatrupron, et al.
Publicado: (2014)

Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions
por: Chen, Zhibin, et al.
Publicado: (2014)

Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients
por: Sukasem, Chonlaphat, et al.
Publicado: (2018)

Retrospective Study of Reported Adverse Events Due to Complementary Health Products in Singapore From 2010 to 2016
por: Xu, Yimin, et al.
Publicado: (2018)

Severe Cutaneous Adverse Reaction Caused by Carbamazepine and Levofloxacin After Varicella Zoster Virus Infection
por: Wang, Meifang, et al.
Publicado: (2023)

HLA-A∗24:02 associated with lamotrigine-induced cutaneous adverse drug reactions: A systematic review and meta-analysis
por: Li, Wanshu, et al.
Publicado: (2020)

The HLA-A*31:01 allele: influence on carbamazepine treatment
por: Yip, Vincent Lai Ming, et al.
Publicado: (2017)

Diagnostic Utility of Human Leukocyte Antigen B*15:02 Screening in Severe Carbamazepine Hypersensitivity Syndrome
por: Moutaouakkil, Youssef, et al.
Publicado: (2019)

A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
por: Ko, Tai-Ming, et al.
Publicado: (2014)

Association Between HLA Genotype and Cutaneous Adverse Reactions to Antiepileptic Drugs Among Epilepsy Patients in Northwest China
por: Wang, Xu, et al.
Publicado: (2019)

HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2017)

A Single SNP Surrogate for Genotyping HLA-C*06:02 in Diverse Populations
por: Stuart, Philip E., et al.
Publicado: (2014)

HLA-DRB1∗16:01 and HLA-DQB1∗05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma
por: Wang, Xu, et al.
Publicado: (2021)

Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions
por: Manson, Lisanne E. N., et al.
Publicado: (2022)

Rapid Multiplex Genotyping of 20 HLA-A(*)02:01 Restricted Minor Histocompatibility Antigens
por: Romaniuk, Dmitrii S., et al.
Publicado: (2019)

HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure
por: Khor, Seik-Soon, et al.
Publicado: (2021)

Epidemiology and economic burden of bronchiectasis requiring hospitalisation in Singapore
por: Phua, Hwee Pin, et al.
Publicado: (2021)

Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
por: Wong, Si Xian, et al.
Publicado: (2019)

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
por: Koomdee, Napatrupron, et al.
Publicado: (2017)

Markedly Elevated Carbamazepine-10,11-epoxide/Carbamazepine Ratio in a Fatal Carbamazepine Ingestion
por: Russell, Jason L., et al.
Publicado: (2015)

HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
por: Kutszegi, Nóra, et al.
Publicado: (2017)

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
por: Ko, Tai-Ming, et al.
Publicado: (2015)

Association between HLA gene polymorphism and cutaneous adverse reactions caused by antiepileptic drugs
por: Zhang, Jingang, et al.
Publicado: (2018)

Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics
por: Esmaeilzadeh, Hossein, et al.
Publicado: (2019)

Non-Recurrence of Carbamazepine Induced Vitiligo after Rechallenge with Carbamazepine
por: Saeedloo, Masoomeh, et al.
Publicado: (2013)

Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele
por: Sakurada, Kumi, et al.
Publicado: (2018)

Hepatoprotective and antioxidant activity of N-acetyl cysteine in carbamazepine-administered rats
por: Maheswari, Eswaran, et al.
Publicado: (2014)

Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital
por: Lee, Jung Eun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kvnecdtai2go0k1mipp7vlh7g0